Literature DB >> 7523191

Single channel activity of the ryanodine receptor calcium release channel is modulated by FK-506.

G P Ahern1, P R Junankar, A F Dulhunty.   

Abstract

The immunosuppressant drug FK-506 (3-20 microM) increased the open probability of ryanodine receptor calcium release channels, formed by incorporation of terminal cisternae vesicles from rabbit skeletal muscle into lipid bilayers, with cis (cytoplasmic) calcium concentrations between 10(-7) M and 10(-3) M. FK-506 increased mean current and channel open time and induced long sojourns at subconductance levels that were between 28% and 38% of the maximum conductance and were distinct from the ryanodine-induced subconductance level at about 45% of the maximum conductance. FK-506 relieved the Ca2+ inactivation of the ryanodine receptor seen at 10(-3) M Ca2+. The results are consistent with FK-506 removal of FK-506 binding protein from the ryanodine receptor.

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7523191     DOI： 10.1016/0014-5793(94)01001-3

Source DB:  PubMed          Journal:  FEBS Lett        ISSN： 0014-5793            Impact factor:   4.124


  48 in total

1.  Inhibition of mouse neuromuscular transmission and contractile function by okadaic acid and cantharidin.

Authors:  S J Hong
Journal:  Br J Pharmacol       Date:  2000-07       Impact factor: 8.739

2.  Calsequestrin is an inhibitor of skeletal muscle ryanodine receptor calcium release channels.

Authors:  Nicole A Beard; Magdalena M Sakowska; Angela F Dulhunty; Derek R Laver
Journal:  Biophys J       Date:  2002-01       Impact factor: 4.033

3.  The three-dimensional structural surface of two beta-sheet scorpion toxins mimics that of an alpha-helical dihydropyridine receptor segment.

Authors:  Daniel Green; Suzi Pace; Suzanne M Curtis; Magdalena Sakowska; Graham D Lamb; Angela F Dulhunty; Marco G Casarotto
Journal:  Biochem J       Date:  2003-03-01       Impact factor: 3.857

4.  Peptide fragments of the dihydropyridine receptor can modulate cardiac ryanodine receptor channel activity and sarcoplasmic reticulum Ca2+ release.

Authors:  Angela F Dulhunty; Suzanne M Curtis; Louise Cengia; Magdalena Sakowska; Marco G Casarotto
Journal:  Biochem J       Date:  2004-04-01       Impact factor: 3.857

5.  Regulation of ryanodine receptors by calsequestrin: effect of high luminal Ca2+ and phosphorylation.

Authors:  Nicole A Beard; Marco G Casarotto; Lan Wei; Magdolna Varsányi; Derek R Laver; Angela F Dulhunty
Journal:  Biophys J       Date:  2005-02-24       Impact factor: 4.033

6.  The conformation of calsequestrin determines its ability to regulate skeletal ryanodine receptors.

Authors:  Lan Wei; Magdolna Varsányi; Angela F Dulhunty; Nicole A Beard
Journal:  Biophys J       Date:  2006-05-12       Impact factor: 4.033

7.  Calsequestrin content and SERCA determine normal and maximal Ca2+ storage levels in sarcoplasmic reticulum of fast- and slow-twitch fibres of rat.

Authors:  Robyn M Murphy; Noni T Larkins; Janelle P Mollica; Nicole A Beard; Graham D Lamb
Journal:  J Physiol       Date:  2008-11-24       Impact factor: 5.182

8.  Tacrolimus reduces nitric oxide synthase function by binding to FKBP rather than by its calcineurin effect.

Authors:  Leslie G Cook; Valorie L Chiasson; Cheng Long; Gang-Yi Wu; Brett M Mitchell
Journal:  Kidney Int       Date:  2009-01-28       Impact factor: 10.612

9.  In vitro modulation of the cardiac ryanodine receptor activity by Homer1.

Authors:  Pierre Pouliquin; Suzy M Pace; Angela F Dulhunty
Journal:  Pflugers Arch       Date:  2009-03-19       Impact factor: 3.657

10.  Inhibition of a cardiac sarcoplasmic reticulum chloride channel by tamoxifen.

Authors:  Sanja Beca; Evgeny Pavlov; Margaret E Kargacin; Roozbeh Aschar-Sobbi; Robert J French; Gary J Kargacin
Journal:  Pflugers Arch       Date:  2008-05-06       Impact factor: 3.657
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.